Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience

• 主要な著者: Lauren E. Brownell (著者), Meagan L. Adamsick (著者), Erin K. McCreary (著者), Joshua P. Vanderloo (著者), Erika J. Ernst (著者), Emily R. Jackson (著者), Lucas T Schulz (著者)
• フォーマット: 図書
• 出版事項: Adis, Springer Healthcare, 2020-06-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background Vancomycin treatment of complicated Gram-positive infections is associated with laboratory monitoring, nephrotoxicity, and multiple daily dosing. Oritavancin, a lipoglycopeptide antibiotic with a once-weekly dosing strategy and similar but slightly broader spectrum of activity, p...